Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Modulators of the activity of IL-13 investigated at Amrad

July 1, 1998

Fujisawa scientists identify potent, nonpeptide bradykinin antagonist

June 30, 1998

Boehringer Ingelheim presents new leukotriene antagonists

June 30, 1998

Rhone-Poulenc Rorer seeks FDA approval for CFC-free Intal Inhaler

June 30, 1998

SciClone's lead cystic fibrosis drug found safe in phase I

June 29, 1998

TOBI efficacy maintained in longer term studies

June 25, 1998

RCT reports new HLE inhibitors

June 25, 1998

Another European market introduction for mizolastine

June 23, 1998

New cell adhesion inhibitors from Chiroscience

June 23, 1998

PKC inhibitors for inflammatory/immune disorders developed at Astra

June 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...